摘要
According to GLOBOCAN 2018,the global cancer statistic database by the International Agency for Research on Cancer,breast cancer is the most commonly diagnosed cancer in women.[1]In 2018,more than 2 million new breast cancer cases were reported,with an age standardized rate(ASR)of 46.3 per 100,000,and over 600,000 deaths from breast cancer were estimated,with an ASR of 13.0 per 100,000,worldwide.The number of breast cancer cases continues to increase.In China,more than 270,000 new cases were diagnosed in 2015,with 70,000 reported deaths.[2]In 2018,the number of new cases in the country increased to 367,900.[1]Thus,we urgently need more clinical researches and expert consensus on optimal therapies for breast cancer.
